Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.
RNA interference (RNAi) technique has become a valuable tool in biology and biomedicine. In the future, it has the potential for application in many different fields including clinical medicine and agriculture. RNAi is a revolution in biology, representing the natural biological process in which genes are turned off in cells, and a completely new approach to drug discovery and development. This review focuses on the therapeutic potential of RNAi for central nervous system diseases. It gives an overview of the progress which has been made in this field to date, including the application of RNAi in vitro (to neurons) and in vivo (animal disease models) and addresses challenges in developing RNAi-based therapies. This review attempts to describe the future prospective of the clinical application of RNAi for neurodegenerative disorders.